{
    "address": "",
    "city": "Umea",
    "country": "SE",
    "currency": "",
    "cusip": "W5S33K100",
    "description": "Lipigon Pharmaceuticals AB engages in the development of orphan drugs. The company is headquartered in Umea, Vasterbottens. The company went IPO on 2021-03-01. The firm was founded in 1970 and is located in Sweden.",
    "employeeTotal": "",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "N/A",
    "ggroup": "N/A",
    "gind": "N/A",
    "gsector": "N/A",
    "gsubind": "N/A",
    "ipo": "2021-03-01",
    "isin": "SE0015382072",
    "logo": "",
    "marketCapitalization": 74.94,
    "naics": "Pharmaceutical and Medicine Manufacturing",
    "naicsNationalIndustry": "Pharmaceutical Preparation Manufacturing",
    "naicsSector": "Manufacturing",
    "naicsSubsector": "Chemical Manufacturing",
    "name": "Lipigon Pharmaceuticals AB",
    "phone": "46705781768.0",
    "sedol": "BMXD805",
    "shareOutstanding": 9.73,
    "state": "VASTERBOTTENS",
    "ticker": "LPGO.ST",
    "weburl": ""
}